Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer

(1) Background: Exon 20 insertion mutations (ex20ins) in EGFR and HER2 are uncommon driver mutations in non-small-cell lung cancer (NSCLC), with a poor prognosis and few targeted therapy options, and there are limited real-world data. Here, we report the clinicopathologic features and outcomes for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kelly, Bosdet, Ian, Yip, Stephen, Ho, Cheryl, Laskin, Janessa, Melosky, Barbara, Wang, Ying, Sun, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453579/
https://www.ncbi.nlm.nih.gov/pubmed/37622996
http://dx.doi.org/10.3390/curroncol30080515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453579/
https://www.ncbi.nlm.nih.gov/pubmed/37622996
http://dx.doi.org/10.3390/curroncol30080515

Ejemplares similares